NEW YORK (AP) - The technological breakthrough pioneered by George P. Mitchell, the billionaire Texas oilman and philanthropist who died Friday at age 94, reversed the fortunes of the U.S. energy industry and reshaped the global energy landscape.
WASHINGTON (AP) - Federal regulators say they have certified two types of unmanned aircraft for civilian use, a milestone expected to lead to the first approved commercial drone operations later this summer.
SAN FRANCISCO (AP) - Zynga relied on mass layoffs and other cost-cutting to trim its second-quarter losses as the troubled company struggled to come up with compelling games to play on smartphones and tablet computers.
SAN FRANCISCO (AP) - Amazon.com Inc. on Thursday reported a surprise loss in the second quarter, as higher revenue was not enough to make up for rising operating expenses. The world's largest online retailer has been spending heavily on order fulfillment and digital content rights, which continue to weigh on profit margins.
LOS GATOS (AP) - Netflix's Internet video subscription service works around the clock, but it's unusual for more than two dozen of the company's engineers and top managers to be huddled in a conference room at 10:30 on a midsummer Wednesday evening.
SAN FRANCISCO (AP) - Google is betting consumers will pay slightly more for a sleeker, more powerful version of its Nexus 7 tablet as the Internet company escalates its rivalry with Apple and Amazon.com in technology's key battleground - the mobile computing market.
MENO PARK (AP) - Facebook's stock is flying high after the world's biggest social network posted higher revenue from mobile ads and delivered a healthy second-quarter profit that reversed a loss in the same period a year ago.
SAN FRANCISCO (AP) - Did the National Security Agency plant spyware deep in the hard drives of thousands of computers used by foreign governments, banks and other surveillance targets around the world?
WASHINGTON (AP) - The makers of a twice-rejected pill designed to boost sexual desire in women are hoping a yearlong lobbying push by politicians, women's groups and consumer advocates will move their much-debated drug onto the market.